Related by context. All words. (Click for frequent words.) 69 BRCA mutations 68 endometrial cancers 66 chlamydial infection 65 ovarian cancer 65 recurrent miscarriage 64 breast cancer 64 BRCA mutation carriers 64 bowel cancers 64 colorectal cancer CRC 63 BRCA2 mutations 63 breast cancers 63 lobular cancer 63 premature menopause 63 ovarian cancers 63 BRCA mutation 63 atypical hyperplasia 63 ductal breast cancer 62 LQTS 62 BRCA2 gene mutation 62 BRCA1 mutations 62 gene BRCA2 62 BRCA carriers 62 gynecological cancers 62 BRCA genes 62 deCODE BreastCancer TM 62 BRCA2 gene mutations 62 recurrent miscarriages 62 genetic abnormalities 62 genes BRCA1 61 abnormal mammograms 61 nonmelanoma skin cancers 61 HNPCC 61 gynecologic cancers 61 thrombophilia 61 lobular breast cancer 61 aneuploidy 61 ovarian hyperstimulation 61 systemic scleroderma 61 CMV infection 61 prostate cancer CaP 61 anovulatory infertility 61 spontaneous preterm birth 61 ductal cancer 60 chromosomal abnormalities 60 recurrent ovarian cancer 60 atypia 60 polycystic ovary syndrome 60 BRCA1 mutation carriers 60 inherited mutations 60 polycystic ovary syndrome PCOS 60 cervical cancer 60 mutated BRCA1 60 hereditary breast 60 invasive breast cancer 60 BRCA1 gene 60 TGFBR1 * 6A 60 breast endometrial 60 colorectal cancers 60 postmenopausal breast cancer 60 spontaneous preterm delivery 60 nonmelanoma skin cancer 60 gynecologic malignancy 59 anal cancers 59 colorectal cancer 59 breast cancer recurrence 59 contralateral breast cancer 59 Ovary removal 59 breast cancer metastasis 59 endometrial cancer 59 breast cancer Narod 59 precursor lesions 59 testicular cancers 59 Testicular cancer 59 grade cervical dysplasia 59 prenatal diagnosis 59 cancers 59 epithelial ovarian cancer 59 cancerdefine 59 Folate deficiency 59 invasive ductal breast cancer 59 operable breast cancer 59 BRCA2 mutation 59 HER2 overexpression 59 HNSCC 59 bladder cancers 59 invasive cervical cancer 59 prophylactic mastectomy 59 estrogen progestin therapy 59 infertility 59 TTTS 59 testicular germ cell 59 Dr Zorbas 59 genetic syndromes 59 cervical lesions 59 Genetic variants 58 mammographic density 58 HER2 positive breast cancer 58 Endometrial cancer 58 breast cancer susceptibility genes 58 premenopausal breast cancer 58 BRCA2 mutation carriers 58 polycystic ovaries 58 aneuploidies 58 precancerous cervical lesions 58 BRCA1 58 abnormal Pap tests 58 BRCA2 genes 58 ovarian hyperstimulation syndrome OHSS 58 cervical carcinoma 58 preterm deliveries 58 placenta praevia 58 basal cell nevus syndrome 58 pre eclampsia 58 IgA deficiency 58 endometrial carcinoma 58 thromboembolic disease 58 lobular carcinoma 58 colon cancers 58 preeclampsia 58 gynecological cancer 58 FGFR2 gene 58 gynecologic cancer 58 Postnatal depression 58 grade serous ovarian 58 curable cancers 58 Human papillomavirus HPV 58 neoplasia 58 serous ovarian cancer 58 sCJD 58 mitochondrial disorders 58 vaginal cancers 58 squamous cell lung cancer 57 Menopausal hormone therapy 57 perinatal depression 57 CIN2 + 57 breast cancer gene mutation 57 BRCA 57 BRCA2 carriers 57 ependymoma 57 prostate adenocarcinoma 57 adenomatous polyps 57 gestational diabetes mellitus 57 HER2 positive cancers 57 ovarian tumors 57 disease NAFLD 57 multiple gestations 57 endometrial hyperplasia 57 chromosome abnormality 57 Li Fraumeni 57 uterine cancers 57 invasive carcinoma 57 cervical precancer 57 polycystic ovarian syndrome PCOS 57 ovarian breast 57 premenstrual syndrome PMS 57 chromosomal disorders 57 prostate cancers 57 BRCA1 mutation 57 ALCL 57 ectopic pregnancies 57 Folic acid supplements 57 seminoma 57 pre cancerous polyps 57 de ath 57 precancerous cervical 57 epigenetic changes 57 bowel cancer 57 transfusion syndrome 57 gene mutations 57 BRCA testing 57 Breast cancer 57 uterine ovarian 57 CIN3 57 AAT deficiency 57 Uterine cancer 57 advanced adenomas 57 gastrointestinal GI cancers 57 Polycystic Ovary Syndrome 57 genetic variants associated 57 CMV disease 57 benign proliferative breast 57 genital herpes infections 57 abnormal mammogram 57 hereditary predisposition 57 subclinical atherosclerosis 57 malignancies 57 invasive ductal 57 unexplained infertility 57 CHEK2 56 BRCA gene mutation 56 malignant melanoma 56 breast tumors 56 diagnostic biomarker 56 breast carcinoma 56 pancreatic adenocarcinoma 56 placental malaria 56 abnormal pap smears 56 estrogen receptor negative 56 colon tumors 56 pre cancerous lesions 56 leiomyomas 56 primary ovarian insufficiency 56 ductal carcinomas 56 Bladder cancer 56 HPV genotypes 56 Metastases 56 choriocarcinoma 56 Epithelial ovarian cancer 56 BRCA2 56 prostate cancer 56 venous blood clots 56 Chlamydia infection 56 benign breast 56 ADPKD 56 Heavy menstrual bleeding 56 benign growths 56 sentinel lymph node biopsy 56 GISTs 56 chromosomal defect 56 Recurrences 56 ovarian pancreatic 56 Acute lymphoblastic leukemia 56 colorectal neoplasia 56 Uterine fibroids 56 RhD 56 breast cancer genes BRCA1 56 familial adenomatous polyposis 56 preventive mastectomies 56 atypical ductal hyperplasia 56 colorectal neoplasms 56 aneuploidy screening 56 Aneuploidy 56 mtDNA mutations 56 fetal malformations 56 DVT PE 56 peritoneal cancer 56 neuroblastoma tumors 56 tumor recurrence 56 uterine cancer 56 PARP inhibition 56 grade gliomas 56 prostate pancreatic 56 cervical abnormalities 56 neuroblastomas 56 prophylactic mastectomies 56 gastric cancers 56 Pap smear screening 56 narcolepsy cataplexy 56 abnormal cervical 56 grade cervical intraepithelial 56 oophorectomy 56 ovarian hyperstimulation syndrome 56 hormone therapy estrogen 56 HPV infections 56 chlamydia infection 56 Stomach cancer 56 ovulatory cycles 56 methylation markers 56 undergoing IVF 56 SLNB 56 mammographically 55 MYCN amplification 55 fetal abnormalities 55 Genetic predisposition 55 EBV infection 55 MCAD deficiency 55 abnormal Pap smears 55 osteoporotic fractures 55 N. gonorrhoeae 55 chromosome abnormalities 55 IUGR 55 somatic mutations 55 recurrent VTE 55 gastrointestinal cancers 55 p# mutation 55 BRCA gene mutations 55 pneumococcal infection 55 Adjuvant chemotherapy 55 Prostatitis 55 GBA mutations 55 anal lesions 55 commonest cancers 55 Premature Ovarian Failure 55 metastatic prostate 55 mammary cancers 55 Hashimoto thyroiditis 55 urethritis 55 familial ALS 55 node metastases 55 cervical screening 55 pre malignant lesions 55 CHDs 55 oesophageal cancer 55 malignant melanomas 55 Trichomonas vaginalis 55 catheter angiography 55 vulvar cancers 55 lupus 55 Polycystic ovary syndrome PCOS 55 thyroid nodules 55 abnormal Pap smear 55 leukaemias 55 breast uterine 55 HPV infection 55 heart disease 55 axillary dissection 55 PSA screening 55 prognostic markers 55 familial hypercholesterolemia 55 molecular abnormalities 55 Cristofanilli 55 Bowel cancer 55 MYH9 gene 55 subclinical hyperthyroidism 55 HPVs 55 Malignant Melanoma 55 penile cancers 55 overdiagnosis 55 Male infertility 55 Hepatocellular Carcinoma HCC 55 antigen PSA 55 melanoma 55 FGFR2 55 T1DM 55 gastrointestinal stromal tumors GISTs 55 PTPN# 55 neoplasias 55 genetic mutations 55 pre cancerous 55 androgenetic alopecia 55 folate intake 55 cervical intraepithelial neoplasia 55 irregular menstrual cycles 55 Rh incompatibility 55 lung adenocarcinoma 55 chromosomal rearrangement 55 preterm delivery 55 breast caner 55 esophageal adenocarcinoma 55 chlamydial infections 55 vitamin D deficiency 55 recurrent preterm birth 55 HPV# 55 polyp recurrence 55 thoracic aortic disease 55 faulty BRCA genes 55 microdeletions 55 basal cell carcinoma BCC 55 advanced neoplasia 55 colon adenomas 55 endostatin 55 Pre eclampsia 55 polycystic ovarian syndrome 55 acute lymphoid leukemia 55 RhD negative 55 Genetic testing 54 BRCA1 BRCA2 54 Polycystic Ovarian Syndrome PCOS 54 prostate specific 54 chromosomal anomaly 54 Melanomas 54 HPV 54 lobular carcinomas 54 carotid plaques 54 abnormal Pap test 54 invasive lobular carcinoma 54 basal cell carcinomas 54 BRCA2 gene 54 cervical dysplasia 54 Cervical cancer 54 CDH1 54 colorectal tumors 54 Human Papilloma Virus HPV 54 pre menopausal 54 skin cancers 54 bronchopulmonary dysplasia BPD 54 mammary tumors 54 Human papilloma virus 54 contralateral breast 54 dentinal hypersensitivity 54 ASCUS 54 lymph node biopsies 54 frequently benign tumor 54 Routine screening 54 deCODE BreastCancer 54 chlamydia infections 54 undergoing hysterectomy 54 Human Papillomavirus 54 chromosomal aberrations 54 de novo mutations 54 medulloblastomas 54 Myelodysplastic syndromes MDS 54 G6PD deficiency 54 colorectal adenomas 54 paternal discrepancy 54 melanomas 54 childhood leukemias 54 endometriosis 54 Krabbe Disease 54 breast cancer gene mutations 54 IKZF1 54 HER2 positive 54 DCIS lesions 54 malignant pleural mesothelioma 54 PCNSL 54 endometriosis ovarian cysts 54 human papillomavirus HPV 54 gestational hypertension 54 Cytogenetic 54 cranial radiation 54 TCF#L# gene 54 SRBD 54 epithelial tumors 54 HbF 54 susceptibility gene 54 thyroid cancers 54 Sentinel node biopsy 54 urolithiasis 54 gallstone disease 54 fetal chromosomal 54 respiratory viral infections 54 oropharyngeal cancer 54 Amniocentesis 54 hydrops 54 folic acid intake 54 Epstein Barr virus EBV 54 human papillomaviruses HPV 54 herpes infection 54 Ovarian cancer 54 BRIP1 54 NNRTI resistance 54 estrogen therapy 54 cervical precancers 54 sporadic ALS 54 familial pancreatic cancer 54 Colon polyps 54 ovulation induction 54 colorectal polyps 54 breast ovarian 54 faulty BRCA2 gene 54 aromatase inhibitors AIs 54 testicular tumors 54 breast lesions 54 pelvic inflammatory disease 54 grade glioma 54 warfarin dosing 54 Statin therapy 54 Human Papilloma Virus 54 diagnosis PGD 54 breast carcinomas 54 chronic granulomatous disease 54 placenta accreta 54 detecting colorectal cancer 54 ovarian cervical 54 Vitamin D insufficiency 54 precancerous tumors 54 squamous cell cancers 54 intestinal polyps 54 cancerous breast 54 invasive candidiasis 54 hereditary nonpolyposis colorectal cancer 54 NF1 54 diagnose Alzheimer disease 54 colo rectal cancer 54 HER2 positive tumors 54 cardio vascular disease 54 invasive prenatal 54 sexually transmitted infection 54 alpha thalassemia 54 incidentalomas 54 hypermethylation 54 myeloproliferative neoplasms 54 familial clustering 54 antenatal depression 54 Rectal cancer 54 neoplasia PIN 54 molar pregnancy 54 colonoscopy screenings 54 squamous cell carcinomas 54 Inhibin B 54 Colorectal cancers 54 KIF6 carriers 54 PCa 54 modifiable risk 53 cutaneous melanoma 53 Basal cell 53 basal cell cancers 53 familial hypercholesterolaemia FH 53 varicella infection 53 epithelial ovarian 53 thrombotic events 53 renal cell carcinomas 53 cardiovascular disease CVD 53 low expressors 53 Caesarean deliveries 53 pre cancerous cells 53 intrauterine infection 53 Cholangiocarcinoma 53 metastatic cancer 53 ovarian lung 53 invasive diagnostic 53 thyroid dysfunction 53 Chlamydia infections 53 R0 resection 53 familial predisposition 53 bowel polyps 53 Aortic stenosis 53 perinatal mortality 53 CYP#D# genotype 53 chromosomal defects 53 hereditary hemochromatosis 53 smoldering myeloma 53 BARD1 53 HGPIN 53 cerebral microbleeds 53 CCR5 delta# 53 promoter hypermethylation 53 XMRV infection 53 coinfection 53 differentiated thyroid 53 chromosomal alterations 53 colorectal screenings 53 systemic lupus erythematosus SLE 53 skeletal metastases 53 FSGS 53 Oral contraceptives 53 genetic polymorphisms 53 thrombotic complications 53 obstetric complications 53 hormone therapy HT 53 recurrent ovarian 53 carbohydrate intolerance 53 cervical cancers 53 Gliomas 53 fragility fractures 53 pancreatic lung 53 cervical vaginal 53 carotid stenosis 53 elevated CRP 53 gene mutation 53 cosmetic breast implants 53 tumor subtypes 53 Prostate Specific Antigen PSA 53 CALHM1 53 undergone hysterectomy 53 EUS FNA 53 stratifying patients 53 diagnosed prenatally 53 lung carcinomas 53 Fibroid tumors 53 penetrance 53 fetal aneuploidy 53 chorioamnionitis 53 bronchogenic carcinoma 53 embryonal rhabdomyosarcoma 53 wart virus 53 degenerative neurological diseases 53 pilocytic astrocytomas 53 dysglycemia 53 endogenous estrogen 53 cervical smears 53 pleural mesothelioma 53 Autoimmune diseases 53 HBV infection 53 osteosarcomas 53 lichen planus 53 MGUS 53 TT genotype 53 Digital Mammographic Imaging 53 postnatal depression 53 osteoporotic fracture 53 imatinib resistance 53 myeloid leukemia 53 pCR 53 premature births 53 precancer 53 p# mutations 53 Malignant melanoma 53 prostate cancer PCa 53 P. falciparum malaria 53 malignancy 53 solar keratosis 53 infections STIs 53 renal carcinoma 53 genomewide association studies 53 Thyroid disorders 53 postmenopausal hormone replacement 53 angiosarcoma 53 alveolar rhabdomyosarcoma 53 Vitamin B# deficiency 53 CMV infections 53 genetic disorders 53 Pap smear 53 sonographic diagnosis 53 gestational diabetes 53 Chlamydia trachomatis 53 Androgenetic Alopecia 53 chromosome translocations 53 preterm birth 53 Melasma 53 genomic alterations 53 Peanut allergy 53 preventative mastectomy 53 cancer 53 androgenic alopecia 53 risk HPV genotypes 53 congenital birth defects 53 abnormal vaginal bleeding 53 genital tract infections 53 MammaPrint R 53 BRAF mutation 53 Squamous 53 leukemia ALL 53 postmenopausal hormone therapy 53 cardiac channelopathies 53 subfertility 53 lung metastasis 53 cervical breast 53 genetic variants 53 intensive statin therapy 53 virus XMRV 53 herpes zoster vaccine 53 dysplastic nevi 53 pelvic malignancies 53 rectal cancers 53 histological subtype 53 childhood sunburns 53 dose ionizing radiation 53 chromosome aberrations 53 Chlamydia trachomatis infection 53 epigenetic mechanisms 53 LRP5 53 bacterial vaginosis BV 53 infertility treatments 53 postpartum hemorrhage 53 BRCA gene 53 situ LCIS 53 hypovitaminosis D 53 Preeclampsia 53 fallopian tube carcinoma 53 Screening mammography 53 HER2 expression 53 gastric carcinoma 53 untreated chlamydia 53 subclinical disease 53 aneuploid cells 53 nodal metastases 53 bacterial vaginosis 52 HCV infections 52 endocrine tumors 52 ovarian 52 neural tube birth defects 52 estrogen deficiency 52 sentinel node biopsy 52 deleterious mutation 52 Mitochondrial diseases 52 Sjögren syndrome 52 anovulation 52 Radical prostatectomy 52 Genital warts 52 sexually transmitted infections STIs 52 unneeded biopsies 52 squamous cell carcinoma SCC 52 mild gestational diabetes 52 chronic periodontitis 52 mesotheliomas 52 oesophageal adenocarcinoma 52 microsatellite instability 52 microchimerism 52 onset Alzheimer disease 52 hyperemesis gravidarum 52 gestational diabetes mellitus GDM 52 vCJD epidemic 52 Esophageal cancer 52 Acute Myeloid Leukaemia AML 52 situ DCIS 52 mammographic screening 52 Fibroids 52 colon cancer 52 ICD implantation 52 germline mutation 52 advanced adenoma 52 APOE ε4 52 PMDD 52 Anal cancer 52 neural tube defect 52 malignant growths 52 MSH2 52 HPV subtypes 52 PCOD 52 telomere lengths 52 breast cervical 52 tumor histology 52 nuchal translucency 52 Acute myeloid leukemia 52 invasive pneumococcal disease 52 oncogenic HPV types 52 BRACAnalysis ® 52 Postpartum psychosis 52 taxane therapy 52 vulvodynia 52 Alzheimers disease 52 ErbB2 positive 52 colon polyps 52 testosterone supplementation 52 chronic prostatitis 52 surgical biopsies 52 BRACAnalysis 52 carcinoid tumor 52 baseline mammogram 52 Trisomy 52 premalignant lesions 52 colorectal bowel 52 Recurrence Score 52 symptomatic fibroids 52 cytoreduction 52 HG PIN 52 Autoimmune disorders 52 abnormal cytology 52 cardiovascular disease 52 venous thrombosis 52 untreated celiac disease 52 MDR tuberculosis 52 ventricular dysplasia 52 ALK mutations 52 arterial calcification 52 PTEN mutations 52 axillary lymph nodes 52 basal cell skin 52 distant metastases 52 exfoliation glaucoma 52 Basal cell carcinoma 52 CT colonography CTC 52 Human papillomavirus 52 bronchopulmonary dysplasia 52 PALB2 52 colorectal carcinoma 52 childhood leukemia 52 atypical femur fractures 52 precancerous condition 52 persistent pulmonary hypertension 52 Colorectal cancer CRC 52 chromosomal anomalies 52 microvascular disease 52 abnormal Pap 52 prediabetes 52 KRAS oncogene 52 endometrial 52 enterovirus infection 52 atopic disease 52 ovary transplants 52 Hodgkin lymphoma HL 52 Deep Vein Thrombosis DVT 52 uncontrolled epilepsy 52 curative therapy 52 Liver transplants 52 lobular involution 52 neuroendocrine cancers 52 gene fusions 52 denser breasts 52 extracolonic findings 52 malignant brain 52 immuno compromised individuals 52 susceptibility genes 52 precancers 52 triplet pregnancies 52 perinatal outcomes 52 relapsed ovarian cancer 52 gonococcal infection 52 Li Fraumeni syndrome 52 myeloproliferative disorders 52 Androgen deprivation therapy 52 PPCM 52 Male pattern baldness 52 benign polyps 52 Gastric cancer 52 chromosomal instability 52 genetic aberrations 52 lipid abnormalities 52 abruption 52 caesarean births 52 pneumococcal serotypes 52 Darapladib 52 idiopathic myelofibrosis 52 tumors 52 postoperative pulmonary 52 amino acid homocysteine 52 WT1 52 vitamin B# deficiency 52 recurrent UTI 52 carcinoid 52 breast cancer recurrences 52 tamoxifen 52 precocious puberty 52 #q# deletion 52 cervical smear 52 ovaries removed 52 type 1diabetes 52 gastric adenocarcinoma 52 spinal muscular atrophy SMA 52 preeclamptic 52 Treg cell 52 Cancers 52 genomewide 52 singleton pregnancy 52 CHEK2 gene 52 ovarian hormones 52 vitamin D insufficiency 52 congenital abnormalities 52 ovarian malignancy 52 undiagnosed celiac disease 52 DNA methylation patterns 52 APOL1 52 fibroids endometriosis 52 colon rectal cancer 52 causal variants 52 GNAQ 52 Genetic mutation 52 Postpartum depression 52 Thyroid cancer 52 genetic abnormality 52 uncomplicated pregnancies 52 cardiac dysfunction 52 malignant neoplasm 52 pathogenic mutations 52 periodontal infections 52 Tay Sachs Disease 52 sentinel nodes 52 dysplastic lesions 52 preventing premature births 52 ZNF# 52 uterine tumors 52 preterm births 52 Heavy snorers 52 aromatase inhibitor therapy 52 epithelial cancers 52 obese postmenopausal 52 malignant lesions 52 solid organ transplantation 52 neuroendocrine tumors 52 intracranial stenosis 52 coronary blockages 52 brain lesions 52 urological cancers 52 HER2 gene 52 intravenous bisphosphonates 52 Anaplastic 52 VCFS 52 Clusterin 52 JAK mutations 52 metastatic tumors 52 fronto temporal dementia 52 hepatic toxicity 52 pattern baldness 52 rectal cancer 52 Fanconi Anemia 52 tibolone 52 fluoroquinolone resistance 52 treat menopausal symptoms 52 Retinoblastoma 52 lymph node removal 52 diagnostic modality 52 nonmetastatic 52 Premenopausal 52 Seewaldt 52 latent tuberculosis TB 52 FGFR1 52 Glioblastoma 52 BRAF gene 52 mosaicism 52 colorectal cancer screening 52 hirsutism 52 folate supplementation 52 herpes simplex encephalitis 52 HPV types 52 cesarean births 51 maternal morbidity 51 pre eclamptic 51 thyroid hormone levels 51 Hib disease 51 acoustic neuromas 51 pancreatic cancers 51 HER2 51 acute leukemias 51 prognostic biomarkers 51 cervical vulvar 51 NBCAM 51 cancerous enlargement 51 Genetic variations 51 retinoblastoma 51 Dravet syndrome 51 hormonally sensitive 51 chronic bilirubin encephalopathy 51 holoprosencephaly 51 breast cancer subtypes 51 Genital herpes 51 undergo mastectomy 51 nulliparous women 51 Sporadic CJD 51 Brugada syndrome 51 atherothrombotic disease 51 cytologic 51 uterus womb 51 specific antigen 51 Hormone therapy 51 mutated K ras 51 nodal metastasis 51 facial clefts 51 CHD mortality 51 screening mammography 51 urate levels 51 Invasive Breast Cancer 51 cardiotoxicity 51 Epidemiologic studies 51 selenium intake 51 TACI mutations 51 folate deficiency 51 subclinical hypothyroidism 51 menopause 51 prescribed statins 51 Fanconi anemia 51 keloid formation 51 BREVAGen ™ 51 Inflammatory Breast Cancer 51 preventive mastectomy 51 genomic variants 51 Adenomas 51 urinary symptoms 51 K ras mutations 51 paragangliomas 51 OnDose TM 51 APOE genotype 51 seminomas 51 bilirubin levels 51 EGFR inhibitors 51 renal tumors 51 adrenal function 51 chemopreventive agent 51 varicocele 51 KRAS status 51 LHRH receptor positive 51 SUDEP 51 fibrocystic disease 51 Candida infection 51 APOE gene 51 varicoceles 51 poorer prognosis 51 mammographies 51 FTLD 51 ano genital warts 51 TP# mutation 51 Basal Cell 51 MMR vaccinations 51 primary immunodeficiencies 51 iodine intake 51 thermogram 51 hormonally responsive 51 squamous cell 51 leukodystrophies 51 GIST tumors 51 Chronic pancreatitis 51 genes BRCA 51 rheumatic disease 51 Coronary Heart Disease 51 cardioembolic stroke 51 Lp PLA2 51 CA MRSA infections 51 precancerous colon polyps 51 nonvaccine 51 postmenopausal 51 Pancreatic neuroendocrine tumors 51 Renal Cell Carcinoma RCC 51 Hepatocellular carcinoma HCC 51 prion infection 51 TCF#L# 51 genetic susceptibility 51 Glioma 51 postoperative mortality 51 BRCA1 gene mutation 51 coronary calcification 51 Aspergillus infections 51 MSMB 51 FMRP protein 51 blocked fallopian tubes 51 immunodeficiency diseases 51 inheritable diseases 51 elevated triglyceride levels 51 atrophic gastritis 51 localized prostate cancer 51 reproductive tract infections 51 immunopathology 51 nonalcoholic steatohepatitis NASH 51 Retinopathy 51 presymptomatic 51 genital HPV infections 51 BRAF V#E 51 Neisseria gonorrhoeae 51 LVNC 51 distant metastasis